Erin G. Schuetz
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism 121
- Drug-Induced Hepatotoxicity and Protection 19
- Transplantation top 0.2%
- Renal Transplantation Outcomes and Treatments 11
- Oncology top 0.1%
- Drug Transport and Resistance Mechanisms 104
-
- Pharmacological Effects and Toxicity Studies 33
-
- Hormonal Regulation and Hypertension 25
-
- Estrogen and related hormone effects 15
-
- HIV/AIDS drug development and treatment 8
- Co-authors
- John D. SchuetzJatinder K. LambaPhilip S. GuzelianKenneth E. ThummelSteven WrightonPaul B. WatkinsKazuto YasudaStephen C. Strom
- Cited by
- PharmacologyTransplantationOncology
- Journals
- Cell (1 paper)Proceedings of the National Academy of Sciences (7 papers)The Lancet (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Erin G. Schuetz
197 papers receiving 19.4k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Pharmacology 9.8k
- Transplantation 1.4k
- Oncology 9.7k
- Pediatrics, Perinatology and Child Health 4.0k
- Endocrinology, Diabetes and Metabolism 2.5k
Countries citing papers authored by Erin G. Schuetz
This map shows the geographic impact of Erin G. Schuetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin G. Schuetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin G. Schuetz more than expected).
Fields of papers citing papers by Erin G. Schuetz
This network shows the impact of papers produced by Erin G. Schuetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin G. Schuetz. The network helps show where Erin G. Schuetz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erin G. Schuetz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2018 | 52 | |
| 4 | 2017 | 39 | |
| 5 | 2013 | 61 | |
| 6 | 2012 | 37 | |
| 7 | 2011 | 134 | |
| 8 | 2009 | 200 | |
| 9 | 2009 | 40 | |
| 10 | 2008 | 116 | |
| 11 | 2006 | 112 | |
| 12 | 2006 | 33 | |
| 13 | 2006 | 12 | |
| 14 | The CYP3A4*1B variant is related to the onset of puberty, a known risk factor for the development of breast cancer. | 2003 | 83 |
| 15 | 2003 | 223 | |
| 16 | 2003 | 320 | |
| 17 | 2002 | 44 | |
| 18 | 1994 | 39 | |
| 19 | 1994 | 10 | |
| 20 | Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrixbreakdown → | 1988 | 424 |
About Erin G. Schuetz
Erin G. Schuetz is a scholar working on Pharmacology, Transplantation and Oncology, having authored 198 papers that have together received 19.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (121 papers), Drug Transport and Resistance Mechanisms (104 papers), Pharmacological Effects and Toxicity Studies (33 papers), Hormonal Regulation and Hypertension (25 papers), Drug-Induced Hepatotoxicity and Protection (19 papers), Estrogen and related hormone effects (15 papers), Renal Transplantation Outcomes and Treatments (11 papers) and HIV/AIDS drug development and treatment (8 papers). The work is most often cited by research in Pharmacology (9.8k citations), Transplantation (1.4k citations) and Oncology (9.7k citations). Erin G. Schuetz has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include John D. Schuetz, Jatinder K. Lamba, Philip S. Guzelian, Kenneth E. Thummel, Steven Wrighton, Paul B. Watkins, Kazuto Yasuda, Stephen C. Strom, Yvonne S. Lin and Mary V. Relling. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.